RFK Confirmation sends Moderna Stocks into Freefall

The decision of the Senate Finance Committee today to advance Robert F Kennedy Jr's nomination for Health Secretary to a Senate Floor vote, had an immediate impact on the Health market as Moderna stocks took a deep dive directly following this news.

The final committee vote went right down the wire, with 14 Republicans backing the bid, and 13 Democrats voting against it. It was clear during the Committee hearings that the opposition to RFK's bid relates not so much to his general health policies, as it does to his anti-vaccination stance. The specter of massive class-action lawsuits against pharmaceutical companies like Moderna, for their misrepresentations and fraud during the Covid "pandemic", looms large in the near future; making this an extremely high-stake game from which Mr. Kennedy will only walk away victorious if he gets Republican Senators' full support on the Senate Floor.